New Edge Wealth, LLC Genmab A/S Transaction History

New Edge Wealth, LLC

$5.41 Billion
Q3 2024

A detailed history of New Edge Wealth, LLC transactions in Genmab A/S stock. As of the latest transaction made, New Edge Wealth, LLC holds 120,733 shares of GMAB stock, worth $2.49 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

120,733

Previous 112,439 7.38%

Holding current value

$2.49 Million

Previous $2.83 Million 4.18%

% of portfolio

0.05%

Previous 0.06%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$23.84 - $28.48 $197,728 - $236,213	8,294 Added 7.38%	120,733 $2.94 Million
Q2 2024 Aug 01, 2024	BUY	$25.13 - $30.27 $297,338 - $358,154	11,832 Added 11.76%	112,439 $2.83 Million
Q1 2024 May 06, 2024	SELL	$26.43 - $32.77 $512,266 - $635,148	-19,382 Reduced 16.15%	100,607 $3.01 Million
Q4 2023 Jan 29, 2024	BUY	$27.94 - $35.44 $1.13 Million - $1.43 Million	40,382 Added 50.73%	119,989 $3.82 Million
Q3 2023 Nov 08, 2023	BUY	$35.27 - $42.24 $617,965 - $740,087	17,521 Added 28.22%	79,607 $2.81 Million
Q2 2023 Aug 09, 2023	BUY	$37.4 - $42.94 $569,751 - $654,147	15,234 Added 32.52%	62,086 $2.36 Million
Q1 2023 May 08, 2023	BUY	$34.88 - $43.22 $726,759 - $900,531	20,836 Added 80.09%	46,852 $1.77 Million
Q4 2022 Feb 14, 2023	SELL	$33.8 - $47.06 $147,030 - $204,711	-4,350 Reduced 14.33%	26,016 $1.1 Million
Q3 2022 Nov 14, 2022	BUY	$31.52 - $373.61 $135,693 - $1.61 Million	4,305 Added 16.52%	30,366 $976,000
Q2 2022 Aug 09, 2022	BUY	$26.83 - $38.57 $547,117 - $786,519	20,392 Added 359.71%	26,061 $847,000
Q1 2022 May 10, 2022	SELL	$30.95 - $39.68 $5,323 - $6,824	-172 Reduced 2.94%	5,669 $205,000
Q4 2021 Jan 31, 2022	SELL	$35.87 - $47.12 $6,564 - $8,622	-183 Reduced 3.04%	5,841 $231,000
Q3 2021 Nov 12, 2021	BUY	$41.55 - $48.72 $32,325 - $37,904	778 Added 14.83%	6,024 $263,000
Q2 2021 Aug 11, 2021	BUY	$32.88 - $44.57 $172,488 - $233,814	5,246 New	5,246 $214,000

Others Institutions Holding GMAB

# of Institutions

236

Shares Held

52.5M

Call Options Held

10.2K

Put Options Held

25.5K

View Full List

About GENMAB A/S

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $13.6B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

More about GMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Wealth, LLC with notifications on news.

Account

New Edge Wealth, LLC Genmab A/S Transaction History